Exclusive Monopoly for the High-Prescribing Keptos 25/4 Tablet

Name: Adenosine 6mg Injection Antiarrhythmic PCD Franchise
Brand: Adenovin Injection
Rating: 4.8 (150 reviews)

Target Orthopedics & Rheumatology with Dual-Action Superiority

Keptos Edge: Ultra-Fast Analgesia with Central Muscle Relaxation

Higher Patient Satisfaction for Acute Back Pain & Sprains

Low Investment, High-Value Segment: Maximize Ortho Profit Margins

Launch Your Orthopedic Pain Management Business Now!

Home/Products /adenosine-6mg-injection

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Emergency injection PCD franchise in Bangalore

Hospital supply monopoly for cardiology drugs

Investment details Adenosin 6 mg tablets India

Adenosine 6mg Injection Scientific Literature PDF

Adenovin Injection

Composition : Adenosine (6mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 2ml

Price : ₹0/-

Please Contact For Best Price

Adenovin Injection (Adenosine 6 mg Injection) is an indispensable antiarrhythmic agent known for its ultra-rapid onset and extremely short half-life (< 10 seconds), making it the drug of choice for the acute management of supraventricular tachycardias (SVT) as per global Advanced Cardiac Life Support (ACLS) protocols.

Key Commercial Value & Clinical Edge:

Therapeutic Action: Rapidly depresses conduction through the AV node, effectively terminating re-entry circuits that cause Paroxysmal Supraventricular Tachycardia (PSVT) and Wolff-Parkinson-White Syndrome.
Diagnostic Utility: Essential for pharmacologic stress testing (Myocardial Perfusion Scintigraphy) in patients unable to undergo physical exercise, offering a crucial diagnostic alternative in cardiology.
Safety Profile: Due to its rapid metabolism (deamination or phosphorylation), its effects are extremely transient, which is highly valued by emergency physicians and cardiologists for controlled intervention.
Target Market: The product's demand is driven by the consistent need in Hospital Emergency Rooms, Cardiac Care Units (CCUs), and Cardiology Diagnostic Centers across all tiers of healthcare.

This is a critical-care product with non-negotiable hospital stock requirements. Securing the Adenovin franchise guarantees you access to a recession-proof, high-turnover institutional segment. Invest in reliability; invest in Adenovin.

About the Product

Key Commercial Value & Clinical Edge:

Therapeutic Action: Rapidly depresses conduction through the AV node, effectively terminating re-entry circuits that cause Paroxysmal Supraventricular Tachycardia (PSVT) and Wolff-Parkinson-White Syndrome.
Diagnostic Utility: Essential for pharmacologic stress testing (Myocardial Perfusion Scintigraphy) in patients unable to undergo physical exercise, offering a crucial diagnostic alternative in cardiology.
Safety Profile: Due to its rapid metabolism (deamination or phosphorylation), its effects are extremely transient, which is highly valued by emergency physicians and cardiologists for controlled intervention.
Target Market: The product's demand is driven by the consistent need in Hospital Emergency Rooms, Cardiac Care Units (CCUs), and Cardiology Diagnostic Centers across all tiers of healthcare.

Transient side effects may include flushing, chest discomfort, shortness of breath, dizziness, or a feeling of warmth. Rarely, it can cause low blood pressure, palpitations, or transient arrhythmias, which usually resolve quickly after the injection. Medical professionals monitor patients closely during administration to ensure safety.

Adenovin Injection is indicated for the rapid conversion of paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm, including those associated with Wolff-Parkinson-White syndrome. It is also used diagnostically to help identify certain types of tachycardias during cardiac evaluation.

Adenovin Injection should be administered only by qualified healthcare professionals in a hospital or clinical setting with cardiac monitoring available. It should not be used for chronic rhythm management. Inform the doctor if the patient has asthma, heart block, or recent heart attack before administration. Avoid caffeine or theophylline before treatment, as these may reduce the drug’s effectiveness.

Store Adenovin Injection at controlled room temperature (below 25°C), away from light and freezing. Do not use if the solution appears discolored or contains particles. Keep out of reach of children and use only under prescription.